Hu rau:Errol Zhou (Mr.)
Tel: ntxiv 86-551-65523315
Mobile/WhatsApp: ntxiv 86 17705606359
QQ:196299583
Skype:lucytoday@hotmail.com
Email:sales@homesunshinepharma.com
Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj

CAS TSIS TAU: 1513857-77-6
Cov Qauv Nqaij: C24H27F2N5O4
Cov Nqa Molecular: 227.24
EINECS TSIS MUAJ: NA
MDL TSIS TAU: NA
Khoom Qhia:
Khoom npe: pemigatinib CAS TSIS: 1513857-77-6
Txhais:
INCB054828;
3- (2,6-difluoro-3,5-dimethoxyphenyl) -1-ethyl-8 - [(morpholin-4-yl) methyl] -1,3,4,7-tetrahydro-2Hpyrrolo [3' , 2': 5,6] pyrido [4,3-d] pyrimidin-2-ib; INCB-054828;
Tshuaj& Cov Khoom Uas Lub Cev:
Zog: Off-dawb khoom kom dawb khoom
Ntsuas: ≥98.0%
Qhov ceev: 1.44 ± 0.1 g / cm3
Cov ntsiab lus npau: 697.6 ± 55.0 ℃ (Teem Tau)
Cia: Muab cov khoom ruaj khov thiab cov kev daws teeb meem hauv qab no 4 ℃
Solubility: Soluble hauv DMSO
Cov Ntaub Ntawv Kev Nyab Xeeb:
Cov Khoom Muag Khoom: Thauj nyob hauv qab qhov ntsuas kub raws li cov tshuaj tsis muaj phom sij
HS Code: 2933599090
Pemigatinib yog inhibitor ntawm fibroblast kev loj hlob yam receptor hom 1, 2, thiab 3 (FGFR1 / 2/3). Raws li lub npe tshuaj Pemazyre, nws yog siv los ua tshuaj rau kev kho mob ntawm cov neeg laus nrog kev kho yav tas los, kev tiv thaiv tsis tau hauv zos dhau los lossis kev tiv thaiv cholangiocarcinoma.
Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!
Cov khoom lag luam hauv qab patent yog muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.
Cim npe nrov: pemigatinib cas 1513857-77-6, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag